ARCA Biopharma, a Westminster-based company specializing in targeted therapies for cardiovascular diseases, has reported the departure of their President and CEO, Dr. Michael Bristow, and appointment of Thomas Keuer as the new President. This transition took effect on April 3, 2024, when ARCA and Dr. Bristow mutually decided to end his tenure as both an…